Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-26

Clinical Trial Update: Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Single-Arm, Phase II Trial [Phase 2]

View source ↗

Summary

Phase II trial evaluating node-sparing low-dose radiotherapy with chemotherapy and a PD-1 inhibitor in high-risk pMMR/MSS locally advanced colon cancer is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PD-1 inhibitor (undisclosed) (PD-1 inhibitor)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Colon Cancer, Neoadjuvant Therapies | Phase 2 | Status: RECRUITING